Research programme: respiratory disease therapeutics - AlmirallAlternative Names: ADP31417; ADP71296
Latest Information Update: 04 Aug 2015
Price : $50
At a glance
- Originator Almirall S.A.
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Asthma; Chronic obstructive pulmonary disease